These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16682107)

  • 1. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
    Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.
    Aarsland D; Perry R; Larsen JP; McKeith IG; O'Brien JT; Perry EK; Burn D; Ballard CG
    J Clin Psychiatry; 2005 May; 66(5):633-7. PubMed ID: 15889951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A
    J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS; Fagan A; Kissack JC
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
    Sechi G; Agnetti V; Masuri R; Deiana GA; Pugliatti M; Paulus KS; Rosati G
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1043-51. PubMed ID: 11041543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series.
    Takahashi H; Yoshida K; Sugita T; Higuchi H; Shimizu T
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):549-53. PubMed ID: 12691793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of neuroleptic sensitivity in Lewy body disease with a false positive clinical diagnosis of Creutzfeldt-Jakob disease.
    Lemstra AW; Schoenmaker N; Rozemuller-Kwakkel AJ; van Gool WA
    Int J Geriatr Psychiatry; 2006 Nov; 21(11):1031-5. PubMed ID: 16955430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies.
    Ballard CG; Perry RH; McKeith IG; Perry EK
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):872-5. PubMed ID: 16116579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive effects of quetiapine in a patient with dementia with Lewy bodies.
    Rice T; Dobry Y; Wang E; Novakovic V; Sher L
    Psychogeriatrics; 2013 Mar; 13(1):52-7. PubMed ID: 23551413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia with Lewy bodies. Review of diagnosis and pharmacologic management.
    Frank C
    Can Fam Physician; 2003 Oct; 49():1304-11. PubMed ID: 14594099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Aguglia E
    Am J Alzheimers Dis Other Demen; 2006 Dec-2007 Jan; 21(6):448-53. PubMed ID: 17267378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical neuroleptic malignant syndrome with long-term clozapine.
    Corallo CE; Ernest D
    Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome.
    Majic T; Mell T; Heinz A; Rapp MA
    Int Psychogeriatr; 2010 Jun; 22(4):678-9. PubMed ID: 20199702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report.
    Takahashi M; Ohishi S; Katsumi C; Moriya T; Miyaoka H
    Pharmacopsychiatry; 2005 Jul; 38(4):183-4. PubMed ID: 16025424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial.
    Culo S; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Pollock BG
    Alzheimer Dis Assoc Disord; 2010; 24(4):360-4. PubMed ID: 20625270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.